Page last updated: 2024-11-06

hydroxyphenylazouracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydroxyphenylazouracil: Inhibitor of DNA replication in gram-positive bacteria. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID34444
CHEMBL ID1742076
CHEMBL ID1985422
SCHEMBL ID8145876
MeSH IDM0010774

Synonyms (35)

Synonym
6-[(e)-(4-hydroxyphenyl)azo]pyrimidine-2,4-diol
uracil, 6-[(p-hydroxyphenyl)azo]-
2,3h)-pyrimidinedione, 6-[(4-hydroxyphenyl)azo]-
29050-86-0
6-(p-hydroxyphenylazo)uracil
NSC194250 ,
nsc-194250
NCI60_001621
nsc677287
nsc-677287
6-((4-hydroxyphenyl)diazenyl)-2,4-pyrimidinediol
NCGC00014544
NCI194250
2,4(1h,3h)-pyrimidinedione, 6-((4-hydroxyphenyl)azo)-
nsc 194250
uracil, 6-((p-hydroxyphenyl)azo)-
6-((p-hydroxyphenyl)azo)uracil
hydroxyphenylazouracil
brn 0919894
NCISTRUC2_001822
NCISTRUC1_000661
NCGC00097648-01
6-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-1h-pyrimidine-2,4-dione
CCG-38070
NCGC00014544-02
5-25-18-00244 (beilstein handbook reference)
SCHEMBL8145876
CHEMBL1742076
CHEMBL1985422
6-(p-hydroxyphenylazo)-uracil
6-(p-hydroxyphenylazo)-2,4-dihydroxypyrimidine
6-[(4-hydroxyphenyl)diazenyl]-1h-pyrimidine-2,4-dione
6-[2-(4-hydroxyphenyl)diazenyl]-2,4(1h,3h)-pyrimidinedione
DTXSID801194399
WE3ADR6JZF
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-199033 (84.62)18.7374
1990's3 (7.69)18.2507
2000's2 (5.13)29.6817
2010's1 (2.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.41 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]